Catherine Avery Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Catherine Avery Investment Management's AMGN Position: Q2 2026 in Review
Catherine Avery Investment Management increased its Amgen (AMGN) stake by 10% in Q2 2026, buying an estimated $567K and bringing the position to 17,530 shares worth $6.35M. The position accounts for 2.77% of the portfolio, ranked #15.
Catherine Avery Investment Management first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Catherine Avery Investment Management held 17,530 shares of Amgen worth $6.35M as of Q2 2026.
- Catherine Avery Investment Management bought 1,655 Amgen shares in Q2 2026, an estimated $567K.
- Amgen made up 2.77% of Catherine Avery Investment Management's portfolio in Q2 2026, its #15 holding.
- Catherine Avery Investment Management first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Catherine Avery Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.